Durata Therapeutics, Inc. Reports Second Quarter 2012 Financial and Corporate Results

Published: Sep 04, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics, Inc. (NASDAQ: DRTX), a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses, today announced financial and corporate results for the quarter ended June 30, 2012.

Back to news